tiprankstipranks
Trending News
More News >
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market

Spyre Therapeutics (SYRE) Technical Analysis

Compare
444 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Spyre Therapeutics’s (SYRE) Moving Averages Convergence Divergence (MACD) indicator is -1.84, suggesting Spyre Therapeutics is a Buy.
Spyre Therapeutics’s (SYRE) 20-Day exponential moving average is 14.77, while Spyre Therapeutics’s (SYRE) share price is $12.22, making it a Sell.
Spyre Therapeutics’s (SYRE) 50-Day exponential moving average is 17.70, while Spyre Therapeutics’s (SYRE) share price is $12.22, making it a Sell.

Spyre Therapeutics (SYRE) Pivot Points

Apr 16, 2025, 06:48 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
11.81
12.09
12.55
12.83
13.29
13.57
14.03
Fibonacci
12.09
12.37
12.54
12.83
13.11
13.28
13.57
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Spyre Therapeutics (SYRE) Moving Averages

Apr 16, 2025, 06:48 AM
Period
Simple
Exponential
MA5
12.65Buy
12.73Sell
MA10
12.97Sell
13.34Sell
MA20
15.28Sell
14.77Sell
MA50
18.49Sell
17.70Sell
MA100
21.38Sell
20.85Sell
MA200
25.38Sell
24.71Sell
Spyre Therapeutics’s (SYRE) 10-Day exponential moving average is 13.34, while Spyre Therapeutics’s (SYRE) share price is $12.22, making it a Sell.
Spyre Therapeutics’s (SYRE) 100-Day exponential moving average is 20.85, while Spyre Therapeutics’s (SYRE) share price is $12.22, making it a Sell.
Spyre Therapeutics’s (SYRE) stock price is $12.22 and Spyre Therapeutics’s (SYRE) 50-day simple moving average is 18.49, creating a Sell signal.
Spyre Therapeutics’s (SYRE) stock price is $12.22 and Spyre Therapeutics’s (SYRE) 100-day simple moving average is 21.38, creating a Sell signal.
Spyre Therapeutics’s (SYRE) stock price is $12.22 and Spyre Therapeutics’s (SYRE) 200-day simple moving average is 25.38, creating a Sell signal.

Spyre Therapeutics (SYRE) Technical Indicators

Apr 16, 2025, 06:48 AM
Name
Value
Implied Action
RSI (14)
35.50
Neutral
STOCH (9,6)
37.36
Neutral
STOCHRSI (14)
22.17
Neutral
MACD (12,26)
-1.84
Buy
ADX (14)
50.77
Sell
Williams %R
-75.56
Buy
CCI (14)
-70.62
Neutral
ATR (14)
1.43
-
Ultimate Oscillator
46.02
Neutral
ROC
-25.32
Sell
Spyre Therapeutics’s (SYRE) Relative Strength Index (RSI) is 35.50, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Trend Strength Indicator (ADX) is 50.77, creating a Sell signal.
Spyre Therapeutics’s (SYRE) Commodity Channel Index (CCI) is -70.62, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Price Rate of Change (ROC) is -25.32, creating a Sell signal.

FAQ

Is SYRE a Buy, Hold, or Sell?
Based on SYRE’s technical indicators, SYRE is a Strong Sell.
    What is SYRE’s RSI (14)?
    SYRE’s RSI (14) is 35.50, which suggests SYRE is a Neutral.
      What is SYRE’s MACD?
      SYRE’s MACD is -1.84, which suggests SYRE is a Buy.
        What is SYRE’s 5-day moving average?
        SYRE’s 5-day moving average is 12.65, which suggests SYRE is a Buy.
          What is SYRE’s 20-day moving average?
          SYRE 20-day moving average is 15.28, which suggests SYRE is a Sell.
            What is SYRE’s 50-day moving average?
            SYRE’s 50-day moving average is 18.49, which suggests SYRE is a Sell.
              What is SYRE’s 200-day moving average?
              SYRE’s 200-day moving average is 25.38, which suggests SYRE is a Sell.
                What is SYRE’s Williams % R (14)?
                SYRE’s Williams % R (14) is -75.56, which suggests SYRE is a Buy.
                  What is SYRE’s CCI (14)?
                  SYRE’s CCI (14) is -70.62, which suggests SYRE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis